Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology

Ovid Technologies (Wolters Kluwer Health) - Tập 139 Số 25 - 2019
Donald M. Lloyd‐Jones, Lynne T. Braun, Chiadi E Ndumele, Duminda N. Wijeysundera, Laurence S. Sperling, Salim S. Virani, Roger S. Blumenthal

Tóm tắt

Risk assessment is a critical step in the current approach to primary prevention of atherosclerotic cardiovascular disease. Knowledge of the 10-year risk for atherosclerotic cardiovascular disease identifies patients in higher-risk groups who are likely to have greater net benefit and lower number needed to treat for both statins and antihypertensive therapy. Current US prevention guidelines for blood pressure and cholesterol management recommend use of the pooled cohort equations to start a process of shared decision-making between clinicians and patients in primary prevention. The pooled cohort equations have been widely validated and are broadly useful for the general US clinical population. But, they may systematically underestimate risk in patients from certain racial/ethnic groups, those with lower socioeconomic status or with chronic inflammatory diseases, and overestimate risk in patients with higher socioeconomic status or who have been closely engaged with preventive healthcare services. If uncertainty remains for patients at borderline or intermediate risk, or if the patient is undecided after a patient–clinician discussion with consideration of risk enhancing factors (eg, family history), additional testing with measurement of coronary artery calcium can be useful to reclassify risk estimates and improve selection of patients for use or avoidance of statin therapy. This special report summarizes the rationale and evidence base for quantitative risk assessment, reviews strengths and limitations of existing risk scores, discusses approaches for refining individual risk estimates for patients, and provides practical advice regarding implementation of risk assessment and decision-making strategies in clinical practice.

Từ khóa


Tài liệu tham khảo

10.1161/circ.106.25.3143

Fuster, V, Pearson, TA. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol. 1996;27:957–1047.

10.1161/01.cir.0000437740.48606.d1

10.1161/01.cir.0000437739.71477.ee

10.1161/01.cir.0000437741.48606.98

10.1161/01.cir.0000437738.63853.7a

10.1161/HYP.0000000000000066

10.1136/heartjnl-2014-305693

Piepoli, MF, Hoes, AW, Agewall, S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart. 2016;37:2315–81.

10.1161/CIR.0000000000000625

10.1016/S0140-6736(12)60367-5

10.1371/journal.pmed.1002538

Karmali, KN, Persell, SD, Perel, P, et al. Risk scoring for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;3:CD006887.

10.1001/jama.2015.6681

10.1161/JAHA.115.001888

Chia, YC, Lim, HM, Ching, SM. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study. BMC Cardiovasc Disord. 2014;14:163.

10.1161/JAHA.117.005676

10.1001/jamainternmed.2014.5336

10.1093/rheumatology/kex038

10.7326/M16-2543

10.7326/M14-1281

DeFilippis, AP, Young, R, McEvoy, JW, et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. Eur Heart. 2017;38:598–608.

10.1001/jamacardio.2016.4494

10.1002/clc.22642

10.1016/j.atherosclerosis.2015.07.033

10.1001/jama.2014.2632

10.1016/j.ijcard.2015.03.067

10.1016/j.jacl.2015.06.005

10.1016/j.mayocp.2016.03.019

10.1001/jamainternmed.2018.2875

10.1016/j.jacc.2015.09.089

10.1016/j.jacc.2015.07.066

Mortensen, MB, Nordestgaard, BG, Afzal, S, et al. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study. Eur Heart. 2017;38:586–94.

10.1001/jama.2014.2630

10.1016/j.jacc.2016.02.055

10.1016/j.amjcard.2017.05.060

10.1161/JAHA.116.003670

10.7326/M17-3011

10.1161/CIRCULATIONAHA.116.022367

10.1161/CIRCULATIONAHA.113.007648

10.1161/CIRCULATIONAHA.116.024246

American College of Cardiology. ASCVD Risk Estimator Plus. Available at: http://tools.acc.org/ASCVD-Risk-Estimator-Plus/#!/calculate/estimate/. Accessed October 16 2018.

American Heart Association. ASCVD Risk Calculator. Available at: https://professional.heart.org/professional/GuidelinesStatements/ASCVDRiskCalculator/UCM_457698_ASCVD-Risk-Calculator.jsp. Accessed October 16 2018.

10.1161/CIRCULATIONAHA.107.699579

10.1001/jama.297.6.611

10.1161/CIRCULATIONAHA.108.814251

10.1136/heartjnl-2015-307668

10.1016/j.jacc.2014.06.1186

10.1161/CIR.0000000000000580

10.1056/NEJMoa1012848

10.1161/CIRCULATIONAHA.108.800235

10.1161/CIRCULATIONAHA.105.548206

10.1161/CIRCOUTCOMES.109.869727

10.1161/CIRCULATIONAHA.108.816694

10.1056/NEJMoa1600176

10.1016/j.jacc.2015.08.857

American College of Cardiology. ASCVD Risk Estimator Plus. Available at: https://www.acc.org/ASCVDApp. Accessed October 16 2018.

Mayo Clinic Shared Decision Making National Resource Center. Available at: https://shareddecisions.mayoclinic.org/decision-aid-information/decision-aids-for-chronic-disease/cardiovascular-prevention/. Accessed October 16 2018.

10.1016/j.jacc.2015.01.043

10.1161/CIRCULATIONAHA.116.025471

10.1007/s11886-015-0666-9

10.1161/CIRCULATIONAHA.115.016846

10.1016/j.jacc.2015.10.058

How Much Does a CT Scan Cost? Available at: https://health.costhelper.com/ct-scan.html. Accessed August 13 2018.

10.1016/j.jcct.2016.11.003

10.1007/s10554-015-0799-3

10.1016/j.amjmed.2008.05.040

10.1007/s12350-015-0223-3

10.1148/radiol.2017161659

10.1016/j.jacr.2018.04.029

10.1016/j.jcmg.2018.04.015

10.1016/j.dib.2016.01.002

10.1016/j.jcmg.2016.03.022

10.1016/j.jacc.2016.05.084

10.1001/jamacardio.2017.0944

10.1016/j.atherosclerosis.2016.09.060

The Multi-Ethnic Study of Atherosclerosis. CAC Score Reference Values. Available at: https://www.mesa-nhlbi.org/Calcium/input.aspx. Accessed October 16 2018.

10.1161/CIRCULATIONAHA.115.018524

10.1001/jamacardio.2016.5493

10.1001/jama.2016.17020

10.1016/j.jacc.2015.08.035

10.3349/ymj.2017.58.1.82

10.1161/CIRCULATIONAHA.116.027034

10.1161/CIRCULATIONAHA.117.031951

10.1016/j.jacc.2010.11.053

10.1016/j.jcmg.2012.01.022

10.1016/j.jcmg.2017.01.030

10.1016/S0735-1097(17)35217-8

10.1001/jama.2015.7515

Lloyd-Jones, DM, Huffman, MD, Karmali, KN, et al. Estimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients: the Million Hearts Longitudinal ASCVD Risk Assessment Tool: a special report from the American Heart Association and American College of Cardiology [published correction appears in Circulation. 2017;135:e824–e825]. Circulation. 2016;135:e793–813.

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 139 Số 25

Thông tin tác giả